Kale AD, Mane DR, Shukla
D. Expression of transforming growth factor β and its correlation with lipodystrophy in oral submucous
fibrosis: An immunohistochemical study. Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18 (1):e12-8.
doi:10.4317/medoral.18226
http://dx.doi.org/doi:10.4317/medoral.18226
1. Borle RM, Borle
SR. Management of oral submucous fibrosis: a
conservative approach. J Oral Maxillofac Surg. 1991;49:788-91. |
|
|
|
2. Angadi PV. Little evidence that current
interventions can benefit patients with OSMF. Evid
Based Dent. 2011;12:43. |
|
|
|
3. Pindborg JJ, Sirsat
SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol. 1966;22:764-79. |
|
|
|
4. Binnie WH, Cawson
RA. A new ultrastructural finding in oral submucous fibrosis. Br
J Dermatol. 1972;86:286-90. |
|
|
|
5. Haque MF, Harris M, Meghji
S, Barrett AW. Immunolocalization of cytokines and
growth factors in oral submucous fibrosis. Cytokine. 1998;10:713-9. |
|
|
|
6. Kollias HD, McDermott JC. Transforming
growth factor-beta and myostatin signaling in
skeletal muscle. J Appl
Physiol. 2008;104:579-87. |
|
|
|
7. Roberts AB, Anzano MA, Lamb LC, Smith JM,
Sporn MB. New class of transforming growth factors
potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci
U S A. 1981;78:5339-43. |
|
|
|
8. Alevizopoulos A, Mermod
N. Transforming growth factor-beta: the breaking open of a black box. Bioessays. 1997;19:581-91. |
|
|
|
9. Prime SS, Pring M, Davies M, Paterson IC.
TGF-beta signal transduction in oro-facial health
and non-malignant disease (part I). Crit Rev Oral Biol Med. 2004;15:324-36. |
|
|
|
10. Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC. The upregulation of type I plasminogen
activator inhibitor in oral submucous fibrosis. Oral Oncol. 2003;39:367-72. |
|
|
|
11. Cutroneo KR. TGF-beta-induced fibrosis
and SMAD signaling: oligo decoys as natural
therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen. 2007;15:S54-60. |
|
|
|
12. Rajalalitha P, Vali
S. Molecular pathogenesis of oral submucous
fibrosis--a collagen metabolic disorder. J Oral Pathol
Med. 2005;34:321-8. |
|
|
|
13. Feres-Filho
EJ, Choi YJ, Han X, Takala
TE, Trackman PC. Pre- and post-translational
regulation of lysyl oxidase
by transforming growth factor-beta 1 in osteoblastic
MC3T3-E1 cells. J Biol
Chem. 1995;270:30797-803. |
|
|
|
14. Hong HH, Uzel MI, Duan
C, Sheff MC, Trackman PC. Regulation of lysyl oxidase, collagen, and
connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest. 1999;79:1655-67. |
|
|
|
15. Ihn H. Pathogenesis of fibrosis: role of
TGF-beta and CTGF. Curr Opin
Rheumatol. 2002;14:681-5. |
|
|
|
16. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, et al. Transforming growth factor-beta1
induces the differentiation of myogenic cells into
fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol. 2004;164:1007-19. |
|
|
|
17. Clouthier DE, Comerford
SA, Hammer RE. Hepatic fibrosis, glomerulosclerosis,
and a lipodystrophy-like syndrome in
PEPCK-TGF-beta1 transgenic mice. J Clin Invest.
1997;100:2697-713. |
|
|
|
18. Feng Y, Ling T. [Changes of cytokines
secreted by human oral mucosa keratinocytes from
oral submucous fibrosis in vitro]. Hua Xi Kou Qiang Yi Xue
Za Zhi. 2000;18:23-5. |
|
|
|
19. Gao Y, Ling T, Wu H. [Expression of
transforming growth factor beta 1 in keratinocytes
of oral submucous fibrosis tissue]. Zhonghua Kou Qiang
Yi Xue Za Zhi. 1997;32:239-41. |
|
|
|
20. Hsu HJ, Chang KL, Yang YH, Shieh TY. The
effects of arecoline on the release of cytokines
using cultured peripheral blood mononuclear cells from patients with oral
mucous diseases. Kaohsiung J Med Sci. 2001;17:175-82. |
|
|
|
21. Tan JT, McLennan SV, Song WW, Lo LW, Bonner JG, Williams PF, et
al. Connective tissue growth factor inhibits adipocyte
differentiation. Am J Physiol Cell Physiol. 2008;295:C740-51. |
|
|
|
22. Choy L, Skillington J, Derynck R. Roles of autocrine
TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol. 2000;149:667-82. |
|
|
|
23. Choy L, Derynck R. Transforming growth
factor-beta inhibits adipocyte differentiation by
Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing
C/EBP transactivation function. J Biol Chem. 2003;278:9609-19. |
|
|
|
24. Petruschke T, Röhrig
K, Hauner H. Transforming growth factor beta
(TGF-beta) inhibits the differentiation of human adipocyte
precursor cells in primary culture. Int J Obes Relat Metab
Disord. 1994;18:532-6. |
|
|
|
25. Zuk
PA, Zhu M, Ashjian P, De
Ugarte DA, Huang JI, Mizuno
H, et al. Human adipose tissue is a source of multipotent
stem cells. Mol Biol Cell. 2002;13:4279-95. |
|
|
|
26. De Ugarte DA, Morizono K, Elbarbary A,
Alfonso Z, Zuk PA, Zhu M,
et al. Comparison of multi-lineage cells from human adipose tissue and bone
marrow. Cells Tissues Organs. 2003;174:101-9. |
|
|
|
27. Erickson GR, Gimble JM, Franklin DM,
Rice HE, Awad H, Guilak
F. Chondrogenic potential of adipose tissue-derived
stromal cells in vitro and in vivo. Biochem Biophys Res Commun. 2002;290:763-9. |
|
|
|
28. Cho SW, Kim I, Kim SH, Rhie JW, Choi CY, Kim BS. Enhancement of adipose tissue formation
by implantation of adipogenic-differentiated preadipocytes. Biochem Biophys Res Commun. 2006;345:588-94. |